Bispecific antibodies targeting tumor-associated metalloprotease and recruit NK cells - Multifunctional therapeutic approach against oral cancer

Oral Oncol. 2022 Sep:132:106013. doi: 10.1016/j.oraloncology.2022.106013. Epub 2022 Jul 6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Bispecific* / therapeutic use
  • Humans
  • Killer Cells, Natural
  • Metalloproteases
  • Mouth Neoplasms* / therapy
  • Neoplasms*

Substances

  • Antibodies, Bispecific
  • Metalloproteases